- Home
- EVO vs AMC Comparison
EVO vs AMC Comparison
Compare EVO & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- AMC
- Stock Information
- Founded
- EVO 1993
- AMC 1920
- Country
- EVO Germany
- AMC United States
- Employees
- EVO N/A
- AMC N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- AMC Movies/Entertainment
- Sector
- EVO Health Care
- AMC Consumer Discretionary
- Exchange
- EVO Nasdaq
- AMC Nasdaq
- Market Cap
- EVO 1.4B
- AMC 1.2B
- IPO Year
- EVO 2021
- AMC 2013
- Fundamental
- Price
- EVO $3.97
- AMC $3.55
- Analyst Decision
- EVO Buy
- AMC Hold
- Analyst Count
- EVO 2
- AMC 7
- Target Price
- EVO $5.90
- AMC $3.92
- AVG Volume (30 Days)
- EVO 201.5K
- AMC 14.8M
- Earning Date
- EVO 05-06-2025
- AMC 05-07-2025
- Dividend Yield
- EVO N/A
- AMC N/A
- EPS Growth
- EVO N/A
- AMC N/A
- EPS
- EVO N/A
- AMC N/A
- Revenue
- EVO $851,944,444.00
- AMC $4,548,300,000.00
- Revenue This Year
- EVO $10.08
- AMC $7.95
- Revenue Next Year
- EVO $10.99
- AMC $6.09
- P/E Ratio
- EVO N/A
- AMC N/A
- Revenue Growth
- EVO 1.50
- AMC N/A
- 52 Week Low
- EVO $2.84
- AMC $2.45
- 52 Week High
- EVO $5.64
- AMC $5.96
- Technical
- Relative Strength Index (RSI)
- EVO 48.96
- AMC 63.77
- Support Level
- EVO $3.78
- AMC $2.88
- Resistance Level
- EVO $4.80
- AMC $4.08
- Average True Range (ATR)
- EVO 0.14
- AMC 0.26
- MACD
- EVO -0.04
- AMC 0.08
- Stochastic Oscillator
- EVO 18.63
- AMC 62.41
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.